Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice

NeuroImmunoModulation

Volumn 14, Issue 1, 2007, Pages 16-23

  Jamali, Abbas ^a   Bamdad, Taravat ^a   Soleimanjahi, Hoorieh ^a   Pakdel, Firouz Ghaderi ^b   Arefian, Ehsan ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute morphine; Herpes simplex virus 1; Innate resistance

Indexed keywords

CORTICOSTERONE; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; MESSENGER RNA; MORPHINE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; INNATE IMMUNITY; LEUKOCYTE COUNT; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REDUCTION; SINGLE DRUG DOSE; SPLEEN CELL; STATISTICAL SIGNIFICANCE;

ADOPTIVE TRANSFER; ANIMALS; ANTI-INFLAMMATORY AGENTS; CORTICOSTERONE; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNITY, NATURAL; INTERFERON TYPE II; KILLER CELLS, NATURAL; LEUKOCYTES; MICE; MICE, INBRED BALB C; MORPHINE; NARCOTICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34548340685     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107284     Document Type: Article

References (31)

1. Roizman B, Knipe M: Herpes simplex virus and their replication; in Knipe DM, Howley PM, et al (eds): Fields Virology. Philadelphia, Lippincott Williams and Wilkins, 2001, pp 2391-2510.
2. Whitley R, Roizman B: Herpes simplex virus infections. Lancet 2001;357:1513-1518.
3. Koelle DM, Corey L: Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 2003;16:96-113.
4. Vollstedt S, Arnold S, Schwerdel C, Franchini M, Alber G, Di Santo JP, et al: Interplay between α/β and γ interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 2004;78:3846-3850.
5. Carr DJJ: Increased levels of IFN-γ in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J Neuroimmunol 1998;89:160-167.
6. Pinto AJ, Morahan PS, Brinton M, Stewart D, Gavin E: Comparative therapeutic efficacy of recombinant interferons-α, -β, and -γ against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J Interferon Res 1990;10:293-298.
7. Adler H, Beland JL, DelPan NC, Kobzik L, Sobel RA, Rimm IJ: In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J Neuroimmunol 1999;93:208-213.
8. Tanigawa M, Bigger JE, Kanter MY, Atherton SS: Natural killer cells prevent direct anterior-to-posterior spread of herpes simplex virus type 1 in the eye. Invest Ophthalmol Vis Sci 2000;41:132-137.
9. Halford WP, Maender JL, Gebhardt BM: Reevaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1. Virol J 2005;2:56.
10. Rager-Zisman B, Quan PC, Rosner M, Moller JR, Bloom BR: Role of NK cells in protection of mice against herpes simplex virus-1 infection. J Immunol 1987;138:884-888.
11. Al-Khatib A, Campbell IL, Carr DJJ: Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice. J Neuroimmunol 2002;132:41-48.
12. Clark GJ, Angel N, Kato M, López JA, MacDonald K, Vuckovic S, Hart DNJ: The role of dendritic cells in the innate immune system. Microbes Infect 2000;2:257-272.
13. Vallejo R, de Leon-Casasola O, Benyamin R: Opioid therapy and Immunosuppression. Am J Ther 2004;11:354-356.
14. Mc Carthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ: Opioids, Opioid receptors, and the immune response. Drug Alcohol Depend 2001;62:111-123.
15. Friedman H, Newton C, Klein TW: Microbial infection, immunodulation, and drugs of abuse. Clin Microbial Rev 2003;16:209-219.
16. Alonzo N, Carr D: Morphine reduces mortality in mice following ocular infection with HSV-1. Immunopharmacology 1999;41:187-197.
17. Davies PW, Vallejo MC, Shannon KT, Amortegui AJ, Ramanathan S: Oral herpes simplex reactivation after intrathecal morphine: a prospective randomized trial in an obstetric population. Anesth Analg 2005;100:1472-1476.
18. Sheridan P, Moynihan J: Modulation of the innate immune response to HSV-1 following acute administration of morphine: role of hypothalamo-pituitary- adrenal axis. J Neuroimmunol 2005;158:145-152.
19. Saurer TB, Ijames SG, Lysle DT: Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J Neuroimmunol 2006;177:18-26.
20. Gomez-Flores R, Suo JL, Weber RJ: Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav Immun 1999;13:212-224.
21. Hassan ZM, Yaraee R, Zare N, Ghazanfari T, Sarraf Nejad AH, Nazori B: Immunomodulatory affect of R10 fraction of garlic extract on natural killer activity. Int Immunopharmacol 2003;47:1483-1489.
22. Bamdad T, Roostaee MH, Sadeghizadeh M, Mahboudi F, Kazemnejad A, Soleimanjahi H: Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B. Folia Biol (Praha) 2005;51:109-113.
23. Ribeiro-Dias F, Barbuto JAM, Tsujita M, Jancar S: Discrimination between NK and LAK cytotoxic activities of murine spleen cells by MTT assay: differential inhibition by PGE and EDTA. J Immunol Methods 2000;241:121-129.
24. Arefian E, Bamdad T, Soleimanjahi H, Sabahi F, Akhoond MR, Parsania M, Ghaemi A: Evaluation of γ-interferon kinetics in HSV-1 infected mice in different days post infection (in vivo) and post re-stimulation (in vitro). Comp Immunol Microbiol Infect Dis 2007;30:1-9.
25. Freier DO, Fuchs BA: A mechanism of action for morphine induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther 1994;270:1127-1133.
26. Oishi R, Baba M, Nishibori M, Itoh Y, Saeki K: Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice. Naunyn Schmiedebergs Arch Pharmacol 1989;339:159-165.
27. Geiger KD, Nash TC, Sawyer S, Krahl T, Patstone G, Reed JC, et al: Interferon-γ protects against herpes simplex virus type 1-mediated neuronal death. Virology 1997;238:189-197.
28. Appel NM, Kiritsy-Roy JA, Van Loon GR: Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow. Brain Res 1986;378:8-20.
29. Andrade-Mena CE: Inhibition of γ interferon synthesis by catecholamines. J Neuroimmunol 1997;76:10-14.
30. Migliorati G, Nicoletti I, D'Adamio F, Spreca A, Pagliacci C, Riccardi C: Dexamethasone induces apoptosis in mouse natural killer cells and cytotoxic T lymphocytes. Immunology 1994;81:21-26.
31. Munck A, Guyre PM: Glucocorticoids and immune function; in Ader R, Felten D, Cohen N (eds): Psychoneuroimmunology, ed 2. San Diego, Academic Press, 1991, pp 447-474.